Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07910630 |
| Consolidated Lead Sponsor | Jiangsu Jingze Biopharmaceutical Co |
| Therapeutic Condition Cohort | Rare Genetic, Women's Health, and Other |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 48 participants (ESTIMATED) |
| Registered Start Date | 2026-09-08 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The Second Hospital of Anhui Medical University | Hefei, China | Open Hospital Dossier -> |
| Beijing Tongren Hospital, Capital Medical University | Beijing, China | Open Hospital Dossier -> |
| Renmin Hospital of Wuhan University | Wuhan, China | Open Hospital Dossier -> |
| The Second Hospital of Jilin University | Changchun, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.